A visible, targeted high-efficiency gene delivery and transfection strategy

Area of Science:

• Cardiovascular Research
• Gene Therapy
• Biotechnology

Background:

• Myocardial angiogenesis is crucial for treating ischemic heart disease.
• Current gene delivery methods face challenges in efficiency and targeting.
• A novel strategy combining microbubbles and ultrasound was investigated for enhanced gene delivery.

Purpose of the Study:

• To evaluate a new gene delivery strategy for enhancing myocardial angiogenic gene expression.
• To assess the efficacy of microbubbles and ultrasound in improving gene delivery to the myocardium.

Main Methods:

• Direct intramyocardial injection of angiogenic genes (EGFP or HGF) in a canine model.
• Comparison of four treatment groups: gene with microbubbles (MB) and ultrasound (US), gene with US, gene with MB, and gene alone.
• Visualization of microbubble and gene distribution in the myocardium.

Main Results:

• Gene delivery combined with microbubbles and ultrasound (MB/US) resulted in a significant enhancement of gene expression.
• An average 14.7-fold increase in enhanced green fluorescence protein (EGFP) gene expression was observed with MB/US.
• An average 10.7-fold increase in hepatocyte growth factor (HGF) gene expression was achieved with MB/US.
• Capillary density increased significantly from 20.8/mm² to 146.7/mm² in the HGF+MB/US group.

Conclusions:

• Direct intramyocardial injection of angiogenic genes with microbubbles and ultrasound synergistically enhances angiogenesis.
• This novel method provides an observable gene delivery procedure with improved expression efficiency.
• The MB/US technique shows promise for enhancing myocardial gene therapy.